Brains of people with sickle cell disease appear older
A new study led by WashU Medicine researchers has found older-looking brains in adults with sickle cell disease, helping to explain the cognitive challenges experienced by such individuals.
Drug in clinical trials for breast cancer could also treat some blood cancers
Research from WashU Medicine found a possible new treatment strategy for certain types of blood cancers.
New cellular immunotherapy approach shows promise for B-cell lymphoma
A phase 1 clinical trial co-led by researchers at WashU Medicine found that a new type of cell-based immunotherapy was safe for patients with several types of B-cell lymphoma, a type of blood cancer.
Residency Program honored for diversity, equity and inclusion
The Internal Medicine Residency Program at WashU Medicine has received the Accreditation Council for Graduate Medical Education 2025 Barbara Ross-Lee, DO Diversity, Equity, and Inclusion Award.
Immune-targeted approach helps control tuberculosis in mice
Mice infected with the bacteria that cause tuberculosis (TB) fared better when treated with an experimental compound that modulates immune responses, according to a study led by Christina Stallings, a professor of molecular microbiology at WashU Medicine.
Brain structure differences provide clues to substance use risks
Researchers at Washington University found correlations between types of brain structure and people who try drugs before age 15.
Lavine receives grant to study congenital heart disease
Kory Lavine, MD, PhD, the Alan A. and Edith L. Wolff Professor of Cardiology at WashU Medicine, has received a $600,000 grant from the Additional Ventures Foundation — an organization that funds research into congenital heart disease — to study hypoplastic left heart syndrome.
Lanza named fellow of National Academy of Inventors
Gregory Lanza, MD, PhD, the James R. Hornsby Family Professor in Biomedical Sciences at WashU Medicine, has been named a fellow of the National Academy of Inventors in recognition of his application of nanotechnology to a broad variety of medical innovations.
Bagegni receives National Cancer Institute award
Nusayba Bagegni, MD, an associate professor at WashU Medicine, has been awarded a 2024 Early Career Cancer Clinical Investigator Award from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).
Vagus nerve stimulation relieves severe depression
People with severe, treatment-resistant depression who received vagus nerve stimulation therapy showed improvement in depressive symptoms, quality of life and ability to complete everyday tasks, according to a national clinical trial led by researchers at WashU Medicine.
View More Stories